Editors:
- Targeted therapy determined by molecular genetics is emphasized.
- Several imaging techniques for diagnosis and treatment assessment are detailed.
- Present and future therapeutic drugs against malignant gliomas are described.
- The anti-tumor action of cyclosporine A and functionally-related drugs is explained.
- Brain tumor angiogenesis and glioma grading are described.
Part of the book series: Tumors of the Central Nervous System (TCNS, volume 2)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (42 chapters)
-
Front Matter
-
Biomarkers and Diagnosis
-
Front Matter
-
-
Biomarkers And Diagnosis
-
Therapy
-
Front Matter
-
About this book
Editors and Affiliations
-
, Kean University, Room 213, Library building, Union, USA
M.A. Hayat
Bibliographic Information
Book Title: Tumors of the Central Nervous System, Volume 2
Book Subtitle: Gliomas: Glioblastoma (Part 2)
Editors: M.A. Hayat
Series Title: Tumors of the Central Nervous System
DOI: https://doi.org/10.1007/978-94-007-0618-7
Publisher: Springer Dordrecht
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media B.V. 2011
Hardcover ISBN: 978-94-007-0617-0Published: 03 April 2011
Softcover ISBN: 978-94-007-3580-4Published: 29 May 2013
eBook ISBN: 978-94-007-0618-7Published: 03 April 2011
Series ISSN: 2215-096X
Series E-ISSN: 2215-0978
Edition Number: 1
Number of Pages: XXII, 458
Topics: Cancer Research, Neuroradiology, Neurosurgery, Oncology, Pathology, Surgery